Integra LifeSciences Holdings Corporation
IART
$22.48
-$1.48-6.16%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.44M | -10.70M | -12.40M | -3.28M | 19.83M |
| Total Depreciation and Amortization | 44.69M | 21.76M | 43.88M | 30.57M | 30.99M |
| Total Amortization of Deferred Charges | 1.40M | 1.34M | 1.46M | 1.40M | 1.43M |
| Total Other Non-Cash Items | -2.80M | 6.69M | 6.53M | 10.42M | -3.60M |
| Change in Net Operating Assets | -11.99M | 3.39M | 938.00K | -23.35M | 10.09M |
| Cash from Operations | 50.74M | 22.49M | 40.40M | 15.76M | 58.75M |
| Capital Expenditure | -29.60M | -29.65M | -29.71M | -15.47M | -24.54M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 4.18M | 0.00 | -281.99M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.17M | 19.25M | -10.50M | -38.50M | -32.69M |
| Cash from Investing | -4.25M | -10.40M | -322.20M | -53.97M | -57.23M |
| Total Debt Issued | 35.40M | 21.80M | 58.80M | 370.50M | 18.20M |
| Total Debt Repaid | -39.94M | -41.54M | -90.54M | -15.10M | -24.70M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 6.40M | 225.00K |
| Repurchase of Common Stock | -2.61M | -171.00K | -50.08M | -3.12M | -314.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -11.92M | -- | -301.00K |
| Cash from Financing | -7.15M | -19.92M | -93.75M | 358.68M | -6.89M |
| Foreign Exchange rate Adjustments | -8.12M | 7.75M | -1.13M | -4.96M | 8.04M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.22M | -79.00K | -376.67M | 315.50M | 2.67M |
